Personalis, Inc.

NasdaqGM:PSNL 株式レポート

時価総額:US$70.6m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Personalis マネジメント

マネジメント 基準チェック /14

Personalis'の CEO はChris Hallで、 Dec2022年に任命され、 の在任期間は 1.5年です。 の年間総報酬は$ 1.73Mで、 30.9%給与と69.1%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.069%を直接所有しており、その価値は$ 47.60K 。経営陣と取締役会の平均在任期間はそれぞれ2.8年と2年です。

主要情報

Chris Hall

最高経営責任者

US$1.7m

報酬総額

CEO給与比率30.9%
CEO在任期間1.5yrs
CEOの所有権0.07%
経営陣の平均在職期間2.8yrs
取締役会の平均在任期間2yrs

経営陣の近況

Recent updates

Market Cool On Personalis, Inc.'s (NASDAQ:PSNL) Revenues Pushing Shares 25% Lower

Apr 19
Market Cool On Personalis, Inc.'s (NASDAQ:PSNL) Revenues Pushing Shares 25% Lower

Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 31% Yet They're Still Not Telling The Full Story

Mar 02
Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 31% Yet They're Still Not Telling The Full Story

Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 37% Yet They're Still Not Telling The Full Story

Dec 18
Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 37% Yet They're Still Not Telling The Full Story

Will Personalis (NASDAQ:PSNL) Spend Its Cash Wisely?

Dec 04
Will Personalis (NASDAQ:PSNL) Spend Its Cash Wisely?

Personalis (NASDAQ:PSNL) Will Have To Spend Its Cash Wisely

Sep 04
Personalis (NASDAQ:PSNL) Will Have To Spend Its Cash Wisely

Investors Holding Back On Personalis, Inc. (NASDAQ:PSNL)

Apr 17
Investors Holding Back On Personalis, Inc. (NASDAQ:PSNL)

The Prognosis For Personalis

Jun 16

Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?

Jun 09
Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?

Is Personalis (NASDAQ:PSNL) Using Debt In A Risky Way?

Feb 17
Is Personalis (NASDAQ:PSNL) Using Debt In A Risky Way?

Personalis: Getting Personal Again

Feb 02

Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?

Nov 11
Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?

Companies Like Personalis (NASDAQ:PSNL) Are In A Position To Invest In Growth

Oct 12
Companies Like Personalis (NASDAQ:PSNL) Are In A Position To Invest In Growth

We're Hopeful That Personalis (NASDAQ:PSNL) Will Use Its Cash Wisely

Jul 05
We're Hopeful That Personalis (NASDAQ:PSNL) Will Use Its Cash Wisely

CEO報酬分析

Personalis の収益と比較して、Chris Hall の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$93m

Dec 31 2023US$2mUS$534k

-US$108m

Sep 30 2023n/an/a

-US$113m

Jun 30 2023n/an/a

-US$110m

Mar 31 2023n/an/a

-US$114m

Dec 31 2022US$2mUS$83k

-US$113m

報酬と市場: Chrisの 総報酬 ($USD 1.73M ) は、 US市場 ($USD 667.63K ) の同規模の企業の平均を上回っています。

報酬と収益: Chrisの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Chris Hall (55 yo)

1.5yrs

在職期間

US$1,726,790

報酬

Mr. Christopher M. Hall, also known as Chris, served as Senior Vice President and Head of Diagnostics Business at Personalis, Inc. since October 2022 until December 31, 2022 and serves as its President sin...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Christopher Hall
President1.5yrsUS$1.73m0.069%
$ 48.7k
Aaron Tachibana
CFO & COO5.3yrsUS$1.67m0.28%
$ 201.0k
Stephen Moore
Senior VP & Chief Legal Officer4.2yrsUS$674.28k0.14%
$ 96.1k
Richard Chen
Executive VP of R&D and Chief Medical Officer2.9yrsUS$1.28m0.19%
$ 132.5k
Russ Altman
Co-Founder and Member of Clinical & Scientific Advisory Boardno dataデータなしデータなし
Euan Ashley
Co-Founder and Member of Clinical & Scientific Advisory Boardno dataデータなしデータなし
Michael Snyder
Co-Founder and Member of Clinical & Scientific Advisory Boardno dataデータなしデータなし
Michael Fitzpatrick
Vice President of Worldwide Sales11.2yrsデータなしデータなし
Christian Haudenschild
Senior Vice President of Genomic Laboratory Operations2.8yrsデータなしデータなし
Stephane Mouradian
Senior Vice President of Business Development1.4yrsデータなしデータなし
Deepshikha Bhandari
Senior Vice President of Regulatoryless than a yearデータなしデータなし

2.8yrs

平均在職期間

53yo

平均年齢

経験豊富な経営陣: PSNLの経営陣は 経験豊富 であると考えられます ( 2.8年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Christopher Hall
President1.3yrsUS$1.73m0.069%
$ 48.7k
Russ Altman
Co-Founder and Member of Clinical & Scientific Advisory Boardno dataデータなしデータなし
Euan Ashley
Co-Founder and Member of Clinical & Scientific Advisory Boardno dataデータなしデータなし
Michael Snyder
Co-Founder and Member of Clinical & Scientific Advisory Boardno dataデータなしデータなし
Kenneth Widder
Independent Directorless than a yearUS$154.00kデータなし
Karin Eastham
Independent Chair of the Board4.8yrsUS$173.05k0.026%
$ 18.4k
Arthur Bowman
Independent Director5.1yrsUS$121.38k0.026%
$ 18.4k
Woodrow Myers
Independent Director3.3yrsUS$108.88k0.050%
$ 35.5k
John West
Advisor to the Board1.5yrsUS$5.62m0%
$ 0
Lonnie Shoff
Independent Director1.8yrsUS$103.88k0.020%
$ 14.0k
Olivia Bloom
Independent Director2.3yrsUS$116.38k0.034%
$ 23.9k

2.0yrs

平均在職期間

67yo

平均年齢

経験豊富なボード: PSNLの 取締役会経験豊富 ではない ( 2年の平均在任期間) ため、新しい取締役会が必要であると考えられます。